Recently, a regulatory link between MYC and spliceosomal proteins has been indicated for lymphomagenesis and breast cancer; thus, we aimed to perform additional assays on MYC‐related regulation in HCC.[12] First, an investigation of UCSC ChIP‐seq data with an anti‐MYC antibody revealed two MYC‐binding peaks on PD2 promoter in a hepatoma cell line HepG2 and other cell lines (Figure2a). The gene discussed is MYC; the disease is breast carcinoma.